Callan JMB Corp (CJMB) - Forward Price-to-Revenue Multiple

Callan JMB Inc. (CJMB) - corporate logo

Callan JMB Inc (CJMB) is optimizing logistics and implementing sustainable ESG standards into instrument production. This chart of the company's future P/S reflects the impact of Central Bank policy on revenue expectations, where 0.40 serves as the base parameter value. The brand is strengthening its authority among surgeons through device ergonomics, while management develops partnership networks with clinics to commercialize niche products.

CJMB Callan JMB: Forward Price-to-Revenue Multiple in the range 02/06/2025 - 11/13/2026

callanjmb.com - analytical breakdowns and key metrics (CJMB)

- market price and analyst price targets:
Price Chart Callan JMB|CJMB - Fair Value Consensus
- market capitalization indicators:
Market Valuation CJMB|CJMB - Enterprise Value
- business book valuation details:
Net Assets per Single Share Callan JMB|CJMB - Company Net Assets|Market Capitalization to Book Value Ratio callanjmb.com|CJMB - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Callan JMB Inc|CJMB - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Callan JMB|CJMB - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio CJMB|CJMB - Long-Term Debt Volume|Company Short-Term Debts Callan JMB|Quick Ratio callanjmb.com
- business earnings and investment ratios data:
CJMB - Net Profit|Expected Profit Callan JMB Inc|CJMB - Price to Earnings Ratio|Future Price to Earnings Callan JMB|CJMB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple CJMB|CJMB - Operating profit EBITDA|Earnings per share for the last twelve months Callan JMB|CJMB - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months callanjmb.com|CJMB - Earnings per share increase in current year|Net earnings per share growth forecast for next year Callan JMB Inc
- sales and revenue data:
CJMB - Company Total Sales|Company Projected Revenue Callan JMB|CJMB - Market Cap to Revenue|Forward P/S Multiple CJMB
General company analysis:CJMB (Callan JMB Corp)
Original product of Callan JMB Inc.

This indicator is calculated as the ratio of current market capitalization to expected sales volume, allowing for an assessment of the business's market value through the lens of future cash flows. The trend of the forward price-to-sales ratio reflects the discounting of prospects for Callan JMB Inc. (CJMB), where the modernization of CNC workshops and stable capacity utilization of tool assembly lines should ensure sustainable growth in fundamental value.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (icumed.com)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Vascular Inc LMAT|ATRC: Forward P/S Multiple|Forward Price-to-Revenue Multiple STAAR Surgical Co|NAGE (ChromaDex Corporation) - Forward P/S Multiple|Forward P/S Multiple zimvie.com|Price-to-Projected Revenue Ratio AngioDynamics (ANGO)|Price-to-Projected Revenue Ratio CERS (Cerus Corp.)|Price-to-Projected Revenue Ratio Alpha Teknova Inc TKNO|Monogram Orthopedics Inc. - Price-to-Projected Revenue Ratio|Sharps Tech - Forward P/S Multiple|INFU - Forward P/S Multiple|Utah Medical Products, Inc. (UTMD) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue KRMD|Forward Price-to-Revenue Multiple NYXH|MBOT: Forward Price to Sales|Price-to-Projected Revenue Ratio Pro-Dex, Inc. (PDEX)|Price to Expected Revenue Ratio ZTEK|Price-to-Projected Revenue Ratio Elutia ELUT|MLSS - Forward Price-to-Revenue Multiple|NEXGEL, Inc - Forward P/S Multiple|RVP: Price-to-Projected Revenue Ratio|HBIO (Harvard Bioscience, Inc.) - Forward Price-to-Revenue Multiple|femasys.com - Forward Price to Sales|MHUA (Meihua Medical Technologies) - Forward P/S Multiple|Predictive Oncology Corp (POAI) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Atrion Corp (ATRI)|NeuroMetrix Corporation - Market Cap to Projected Revenue